Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bracho

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Alternative and Complementary Medicine (New York, N.Y.)|July 1, 1995
Plants, food and civilization: the lessons of indigenous AmericansF Bracho
Current Opinion in Hematology|July 17, 1998
Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonatesF Bracho, S Goldman, M S Cairo
Histopathology|December 1, 1996
Rosette-forming non-Hodgkin's lymphomasC H Koo, S S Shin, F Bracho, et al.
Bone Marrow Transplantation|April 3, 2001
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC)I Houtenbos, F Bracho, V Davenport, et al.
Cytotherapy|October 28, 2003
A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCsF Bracho, C van de Ven, E Areman, et al.
Journal of Pediatric Hematology/Oncology|July 24, 2001
Feasibility study of IL-11 and granulocyte colony-stimulating factor after myelosuppressive chemotherapy to mobilize peripheral blood stem cells from heavily pretreated patientsS C Goldman, F Bracho, V Davenport, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicitiesF Bracho, M D Krailo, V Shen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Alternative and Complementary Medicine (New York, N.Y.)|July 1, 1995
Plants, food and civilization: the lessons of indigenous AmericansF Bracho
Current Opinion in Hematology|July 17, 1998
Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonatesF Bracho, S Goldman, M S Cairo
Histopathology|December 1, 1996
Rosette-forming non-Hodgkin's lymphomasC H Koo, S S Shin, F Bracho, et al.
Bone Marrow Transplantation|April 3, 2001
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC)I Houtenbos, F Bracho, V Davenport, et al.
Cytotherapy|October 28, 2003
A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: decreased alloreactivity of cord blood DCsF Bracho, C van de Ven, E Areman, et al.
Journal of Pediatric Hematology/Oncology|July 24, 2001
Feasibility study of IL-11 and granulocyte colony-stimulating factor after myelosuppressive chemotherapy to mobilize peripheral blood stem cells from heavily pretreated patientsS C Goldman, F Bracho, V Davenport, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicitiesF Bracho, M D Krailo, V Shen, et al.
Pageof 1